UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 302

Sortiert nach

Erlotinib in the treatment of recurrent or metastatic cutaneous squamous cell carcinoma: A single‐arm phase 2 clinical trial

Cancer, 2018-05, Vol.124 (10), p.2169-2173

2018

Link zum Volltext

Verfügbarkeit prüfen

Novel Systemic Treatment Modalities Including Immunotherapy and Molecular Targeted Therapy for Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma

International journal of molecular sciences, 2022-07, Vol.23 (14), p.7889

2022

Link zum Volltext

Verfügbarkeit prüfen

Defining the role of the JAK-STAT pathway in head and neck and thoracic malignancies: Implications for future therapeutic approaches

Drug resistance updates, 2010-06, Vol.13 (3), p.67-78

2010

Link zum Volltext

Verfügbarkeit prüfen

Dasatinib (BMS-354825) Tyrosine Kinase Inhibitor Suppresses Invasion and Induces Cell Cycle Arrest and Apoptosis of Head and Neck Squamous Cell Carcinoma and Non–Small Cell Lung Cancer Cells

Clinical cancer research, 2005-10, Vol.11 (19), p.6924-6932

2005

Link zum Volltext

Verfügbarkeit prüfen

Phase II Study of the Anti–Insulin-Like Growth Factor Type 1 Receptor Antibody CP-751,871 in Combination With Paclitaxel and Carboplatin in Previously Untreated, Locally Advanced, or Metastatic Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2009-05, Vol.27 (15), p.2516-2522

2009

Link zum Volltext

Verfügbarkeit prüfen

Sustained Src inhibition results in signal transducer and activator of transcription 3 (STAT3) activation and cancer cell survival via altered Janus-activated kinase-STAT3 binding

Cancer research (Chicago, Ill.), 2009-03, Vol.69 (5), p.1958-1965

2009

Link zum Volltext

Verfügbarkeit prüfen

Next-Generation CDK2/9 Inhibitors and Anaphase Catastrophe in Lung Cancer

JNCI : Journal of the National Cancer Institute, 2017-06, Vol.109 (6)

2017

Link zum Volltext

Verfügbarkeit prüfen

Phase II Study of Dasatinib in Patients With Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2010-10, Vol.28 (30), p.4609-4615

2010

Link zum Volltext

Verfügbarkeit prüfen

Gene mutations in primary tumors and corresponding patient-derived xenografts derived from non-small cell lung cancer

Cancer letters, 2015-02, Vol.357 (1), p.179-185

2015

Link zum Volltext

Verfügbarkeit prüfen

Comprehensive pharmacogenomic profiling of human papillomavirus-positive and -negative squamous cell carcinoma identifies sensitivity to aurora kinase inhibition in KMT2D mutants

Cancer letters, 2018-09, Vol.431, p.64-72

2018

Link zum Volltext

Verfügbarkeit prüfen

NOTCH1 Signaling in Head and Neck Squamous Cell Carcinoma

Cells (Basel, Switzerland), 2020-12, Vol.9 (12), p.2677

2020

Link zum Volltext

Verfügbarkeit prüfen

Dinaciclib Induces Anaphase Catastrophe in Lung Cancer Cells via Inhibition of Cyclin-Dependent Kinases 1 and 2

Molecular cancer therapeutics, 2016-11, Vol.15 (11), p.2758-2766

2016

Link zum Volltext

Verfügbarkeit prüfen

ISA101 and nivolumab for HPV-16+ cancer: updated clinical efficacy and immune correlates of response

Journal for immunotherapy of cancer, 2022-02, Vol.10 (2), p.e004232

2022

Link zum Volltext

Verfügbarkeit prüfen

A comprehensive evaluation of biomarkers predictive of response to PI3K inhibitors and of resistance mechanisms in head and neck squamous cell carcinoma

Molecular cancer therapeutics, 2014-11, Vol.13 (11), p.2738-2750

2014

Link zum Volltext

Verfügbarkeit prüfen

Epithelial-Mesenchymal Transition Predicts Polo-Like Kinase 1 Inhibitor-Mediated Apoptosis in Non-Small Cell Lung Cancer

Clinical cancer research, 2016-04, Vol.22 (7), p.1674-1686

2016

Link zum Volltext

Verfügbarkeit prüfen

Wee-1 Kinase Inhibition Sensitizes High-Risk HPV+ HNSCC to Apoptosis Accompanied by Downregulation of MCl-1 and XIAP Antiapoptotic Proteins

Clinical cancer research, 2015-11, Vol.21 (21), p.4831-4844

2015

Link zum Volltext

Verfügbarkeit prüfen

Genomic characterization of human papillomavirus-positive and -negative human squamous cell cancer cell lines

Oncotarget, 2017-10, Vol.8 (49), p.86369-86383

2017

Link zum Volltext

Verfügbarkeit prüfen

A Novel Method for Quantifying Total Thoracic Tumor Burden in Mice

Neoplasia (New York, N.Y.), 2018-10, Vol.20 (10), p.975-984

2018

Link zum Volltext

Verfügbarkeit prüfen

Reciprocal Regulation of c-Src and STAT3 in Non-Small Cell Lung Cancer

Clinical cancer research, 2009-11, Vol.15 (22), p.6852-6861

2009

Link zum Volltext

Verfügbarkeit prüfen

Expression of the Receptor Tyrosine Kinase EphA2 Is Increased in Smokers and Predicts Poor Survival in Non–Small Cell Lung Cancer

Clinical cancer research, 2009-07, Vol.15 (13), p.4423-4430

2009

Link zum Volltext

Verfügbarkeit prüfen

Global evaluation of Eph receptors and ephrins in lung adenocarcinomas identifies EphA4 as an inhibitor of cell migration and invasion

Molecular cancer therapeutics, 2012-09, Vol.11 (9), p.2021-2032

2012

Link zum Volltext

Verfügbarkeit prüfen

Src-Family Kinases Are Activated in Non-Small Cell Lung Cancer and Promote the Survival of Epidermal Growth Factor Receptor-Dependent Cell Lines

The American journal of pathology, 2007, Vol.170 (1), p.366-376

2007

Link zum Volltext

Verfügbarkeit prüfen

SRC family nonreceptor tyrosine kinases as molecular targets for cancer therapy

Anti-cancer agents in medicinal chemistry, 2007-11, Vol.7 (6), p.651

2007

Link zum Volltext

Verfügbarkeit prüfen

A Phase I/II Study Combining Erlotinib and Dasatinib for Non‐Small Cell Lung Cancer

The oncologist (Dayton, Ohio), 2014-10, Vol.19 (10), p.1040-1041

2014

Link zum Volltext

Verfügbarkeit prüfen

Rescue of Immunotherapy-Refractory Metastatic Merkel Cell Carcinoma With Conventionally Fractionated Radiotherapy and Concurrent Pembrolizumab

Frontiers in oncology, 2019-04, Vol.9, p.223

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 302

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(282)
Mit Volltextzugriff
(286)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Erlotinib in the treatment of recurrent or metastatic cutaneous squamous cell carcinoma: A single‐arm phase 2 clinical trial

Novel Systemic Treatment Modalities Including Immunotherapy and Molecular Targeted Therapy for Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma

Defining the role of the JAK-STAT pathway in head and neck and thoracic malignancies: Implications for future therapeutic approaches

Dasatinib (BMS-354825) Tyrosine Kinase Inhibitor Suppresses Invasion and Induces Cell Cycle Arrest and Apoptosis of Head and Neck Squamous Cell Carcinoma and Non–Small Cell Lung Cancer Cells

Phase II Study of the Anti–Insulin-Like Growth Factor Type 1 Receptor Antibody CP-751,871 in Combination With Paclitaxel and Carboplatin in Previously Untreated, Locally Advanced, or Metastatic Non–Small-Cell Lung Cancer

Sustained Src inhibition results in signal transducer and activator of transcription 3 (STAT3) activation and cancer cell survival via altered Janus-activated kinase-STAT3 binding

Next-Generation CDK2/9 Inhibitors and Anaphase Catastrophe in Lung Cancer

Phase II Study of Dasatinib in Patients With Advanced Non–Small-Cell Lung Cancer

Gene mutations in primary tumors and corresponding patient-derived xenografts derived from non-small cell lung cancer

Comprehensive pharmacogenomic profiling of human papillomavirus-positive and -negative squamous cell carcinoma identifies sensitivity to aurora kinase inhibition in KMT2D mutants

NOTCH1 Signaling in Head and Neck Squamous Cell Carcinoma

Dinaciclib Induces Anaphase Catastrophe in Lung Cancer Cells via Inhibition of Cyclin-Dependent Kinases 1 and 2

ISA101 and nivolumab for HPV-16+ cancer: updated clinical efficacy and immune correlates of response

A comprehensive evaluation of biomarkers predictive of response to PI3K inhibitors and of resistance mechanisms in head and neck squamous cell carcinoma

Epithelial-Mesenchymal Transition Predicts Polo-Like Kinase 1 Inhibitor-Mediated Apoptosis in Non-Small Cell Lung Cancer

Wee-1 Kinase Inhibition Sensitizes High-Risk HPV+ HNSCC to Apoptosis Accompanied by Downregulation of MCl-1 and XIAP Antiapoptotic Proteins

Genomic characterization of human papillomavirus-positive and -negative human squamous cell cancer cell lines

A Novel Method for Quantifying Total Thoracic Tumor Burden in Mice

Reciprocal Regulation of c-Src and STAT3 in Non-Small Cell Lung Cancer

Expression of the Receptor Tyrosine Kinase EphA2 Is Increased in Smokers and Predicts Poor Survival in Non–Small Cell Lung Cancer

Global evaluation of Eph receptors and ephrins in lung adenocarcinomas identifies EphA4 as an inhibitor of cell migration and invasion

Src-Family Kinases Are Activated in Non-Small Cell Lung Cancer and Promote the Survival of Epidermal Growth Factor Receptor-Dependent Cell Lines

SRC family nonreceptor tyrosine kinases as molecular targets for cancer therapy

A Phase I/II Study Combining Erlotinib and Dasatinib for Non‐Small Cell Lung Cancer

Rescue of Immunotherapy-Refractory Metastatic Merkel Cell Carcinoma With Conventionally Fractionated Radiotherapy and Concurrent Pembrolizumab

Suchergebnisse filtern